{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:07:19Z","timestamp":1761844039028},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"19-20","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s10354-010-0830-1","type":"journal-article","created":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T08:03:19Z","timestamp":1286956999000},"page":"497-500","source":"Crossref","is-referenced-by-count":1,"title":["W\u00e4chterlymphknotenbiopsie beim Mammakarzinom"],"prefix":"10.1007","volume":"160","author":[{"given":"Gero","family":"Luschin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,1]]},"reference":[{"key":"830_CR1","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/S0140-6736(97)01004-0","volume":"349","author":"U Veronesi","year":"1997","unstructured":"Veronesi U, Paganelli G, Gallimberti V, et al. Sentinel-node biopsy to avoid axillary dissection. Lancet, 349: 1864\u20131867, 1997","journal-title":"Lancet"},{"key":"830_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/cncr.21568","volume":"106","author":"T Kim","year":"2006","unstructured":"Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma. Cancer, 106: 4\u201316, 2006","journal-title":"Cancer"},{"key":"830_CR3","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1056\/NEJMoa012782","volume":"349","author":"U Veronesi","year":"2003","unstructured":"Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med, 349: 546\u2013553, 2003","journal-title":"N Engl J Med"},{"key":"830_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jnci\/djj158","volume":"98","author":"RE Mansel","year":"2006","unstructured":"Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst, 98: 599\u2013609, 2006","journal-title":"J Natl Cancer Inst"},{"key":"830_CR5","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","volume":"8","author":"DN Krag","year":"2007","unstructured":"Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol, 8: 881\u2013888, 2007","journal-title":"Lancet Oncol"},{"key":"830_CR6","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.1200\/JCO.2005.03.228","volume":"23","author":"AD Phurushotham","year":"2005","unstructured":"Phurushotham AD, Upponi S, Klevesath MB, et al. Moribidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol, 23: 4312\u20134321, 2005","journal-title":"J Clin Oncol"},{"key":"830_CR7","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S1470-2045(06)70947-0","volume":"7","author":"U Veronesi","year":"2006","unstructured":"Veronesi U, Paganelli G, Viale G, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol, 7: 983\u2013990, 2006","journal-title":"Lancet Oncol"},{"key":"830_CR8","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00268-001-0011-x","volume":"25","author":"D Clarke","year":"2001","unstructured":"Clarke D, Khonji N, Mansel R. Sentinel node biopsy in breast cancer: ALMANAC trial. World J Surg, 25: 819\u2013822, 2001","journal-title":"World J Surg"},{"key":"830_CR9","doi-asserted-by":"publisher","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","volume":"22","author":"G Lymann","year":"2005","unstructured":"Lymann G, Giuliano A, Sonnenfield M. American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer. JCO, 22: 7703\u20137720, 2005","journal-title":"JCO"},{"key":"830_CR10","unstructured":"S3-Leitlinie zur Diagnostik, Therapie und Nachsorge des Mammakarzinoms 2008, www.senologie.org\/download!pdf\/s3_II_mammaca_11_02_2008.pdf"},{"key":"830_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ejso.2006.09.032","volume":"33","author":"C Lanng","year":"2007","unstructured":"Lanng C, Hoffmann J, Galatius H, et al. Assessment of clinical palpation of the axilla as a criterion for performing the sentinel node procedure in breast cancer. Eur J Surg Oncol, 33: 281\u2013284, 2007","journal-title":"Eur J Surg Oncol"},{"key":"830_CR12","first-page":"41","volume":"131","author":"SJ Cutler","year":"1970","unstructured":"Cutler SJ, Axtell LM, Schottenfeld D, Farrow JH. Clinical assessment of lymph nodes in carcinoma of the breast. Surg Gynecol Obstet, 131: 41\u201352, 1970","journal-title":"Surg Gynecol Obstet"},{"key":"830_CR13","first-page":"765","volume":"152","author":"B Fisher","year":"1981","unstructured":"Fisher B, Wolmark N, Bauer M, et al. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet, 152: 765\u2013772, 1981","journal-title":"Surg Gynecol Obstet"},{"key":"830_CR14","first-page":"169","volume":"12","author":"RA Sacre","year":"1986","unstructured":"Sacre RA. Clinical evaluation of axillar lymph nodes compared to surgical and pathological findings. Eur J Surg Oncol, 12: 169\u2013173, 1986","journal-title":"Eur J Surg Oncol"},{"key":"830_CR15","first-page":"240","volume":"17","author":"R de Freitas Jr","year":"1991","unstructured":"de Freitas R Jr, Costa MV, Schneider SV, et al. Accuracy of ultrasound and clinical examniationin the diagnosis of axillary lymph node metastases in breast cancer. Eur J Surg Oncol, 17: 240\u2013244, 1991","journal-title":"Eur J Surg Oncol"},{"key":"830_CR16","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S0748-7983(96)90593-4","volume":"22","author":"JS Vaidya","year":"1996","unstructured":"Vaidya JS, Vyas JJ, Thakur MH, et al. Role of ultrasonography to detect axillary node involvement in operable breast cancer. Eur J Surg Oncol, 22: 140\u2013143, 1996","journal-title":"Eur J Surg Oncol"},{"key":"830_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jamcollsurg.2004.09.010","volume":"200","author":"MC Specht","year":"2005","unstructured":"Specht MC, Fey JV, Borgen JI, et al. Is the clinical positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy. Am J Surg, 200: 10\u201314, 2005","journal-title":"Am J Surg"},{"key":"830_CR18","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/028418600750013212","volume":"39","author":"L Ilum","year":"2000","unstructured":"Ilum L, Bak M, Olsen K, et al. Sentinel node localisation in breast cancer patients using intradermal dye injection. Acta Oncol, 39: 423\u2013428, 2000","journal-title":"Acta Oncol"},{"key":"830_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1053\/ejso.1998.0594","volume":"25","author":"F van der Ent","year":"1999","unstructured":"van der Ent F, Kent R, van der Pol H, et al. Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10 mCi radiocooloid in combination with a blue dye tracer. Eur J Surg Oncol, 25: 24\u201329, 1999","journal-title":"Eur J Surg Oncol"},{"key":"830_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJMoa0904832","volume":"361","author":"M Boer","year":"2009","unstructured":"Boer M, van Duerzen C, van Dijck J. Mircometastases or isolated tumor cells and the outcome of breast cancer. NEJM, 361: 653\u2013663, 2009","journal-title":"NEJM"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-010-0830-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-010-0830-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-010-0830-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T12:03:54Z","timestamp":1559131434000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-010-0830-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":20,"journal-issue":{"issue":"19-20","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["830"],"URL":"https:\/\/doi.org\/10.1007\/s10354-010-0830-1","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}